Promore Pharma: Q1-report undramatic
Research Note
2018-05-16
16:14
Earlier this afternoon, Promore Pharma released their Q1 report. As expected, no significant news were reported. The company is working on starting the clinical trials with PXL01 and LL-37 during 2018.
MS
Mathias Spinnars
Disclosures and disclaimers